Other OTC - Delayed Quote USD

AVAX Technologies, Inc. (AVXT)

0.0001 0.0000 (0.00%)
As of April 5 at 3:50 PM EDT. Market Open.

Key Executives

AVAX Technologies, Inc.

2000 Hamilton Street
Suite 204
Philadelphia, PA 19130
United States
215-241-9760 https://www.avax-tech.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
9

Description

AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. The company's product candidates that have completed phase II clinical trials include M-VAX for the treatment of melanoma and O-VAX for the treatment for ovarian cancer. It also develops LungVax for the treatment of non-small cell lung cancer. The company was formerly known as Walden Laboratories, Inc. and changed its name to AVAX Technologies, Inc. in March 1996. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.

Corporate Governance

AVAX Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers

HTDS Hard to Treat Diseases Inc.
0.0000
0.00%
 
VTYX Ventyx Biosciences, Inc.
4.3600
+1.40%
 
VSTM Verastem, Inc.
9.79
+0.51%
 
CLSD Clearside Biomedical, Inc.
1.4500
+2.86%
 
VBIV VBI Vaccines Inc.
0.6013
-0.28%
 
BBIO BridgeBio Pharma, Inc.
25.72
+2.59%
 
BRTX BioRestorative Therapies, Inc.
1.3999
+2.18%
 
ARWR Arrowhead Pharmaceuticals, Inc.
24.34
+1.76%
 
IBIO iBio, Inc.
1.9300
+8.43%
 
IBRX ImmunityBio, Inc.
5.31
+7.49%